Identification and validation of GABA-driven subtypes and prognosis signature of lung adenocarcinoma

Clin Transl Med. 2023 Oct;13(10):e1450. doi: 10.1002/ctm2.1450.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma of Lung* / diagnosis
  • Humans
  • Lung Neoplasms* / diagnosis
  • Lung Neoplasms* / genetics
  • Lung Neoplasms* / pathology
  • Prognosis
  • gamma-Aminobutyric Acid

Substances

  • gamma-Aminobutyric Acid